Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.01B |
| 2 |
Microsoft
MSFT
|
+$761M |
| 3 |
Apple
AAPL
|
+$685M |
| 4 |
Amazon
AMZN
|
+$507M |
| 5 |
Cigna
CI
|
+$391M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$741M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$651M |
| 3 |
PX
Praxair Inc
PX
|
+$555M |
| 4 |
COL
Rockwell Collins
COL
|
+$293M |
| 5 |
CA
CA, Inc.
CA
|
+$178M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.64% |
| 2 | Financials | 15.19% |
| 3 | Healthcare | 14.85% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESSA
3001
DELISTED
ESSA Bancorp
ESSA
| $1.16M | ﹤0.01% |
74,486
+4,889
| +7% | +$78.6K |
|
3002
Equinor
EQNR
$92.4B
| $1.16M | ﹤0.01% |
54,919
+5,424
| +11% | +$133K |
|
|
AGFS
3003
DELISTED
AgroFresh Solutions Inc
AGFS
| $1.16M | ﹤0.01% |
305,477
+14,229
| +5% | +$70.8K |
|
3004
First Northwest Bancorp
FNWB
$104M
| $1.16M | ﹤0.01% |
77,965
+4,175
| +6% | +$63.2K |
|
|
USX
3005
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $1.15M | ﹤0.01% |
205,563
+49,606
| +32% | +$417K |
|
3006
ENI
E
$77.5B
| $1.15M | ﹤0.01% |
36,491
+4,104
| +13% | +$139K |
|
|
ENZ
3007
DELISTED
Enzo Biochem, Inc.
ENZ
| $1.14M | ﹤0.01% |
411,138
-61,681
| -13% | -$202K |
|
|
YELL
3008
DELISTED
Yellow Corporation Common Stock
YELL
| $1.14M | ﹤0.01% |
362,826
+17,058
| +5% | +$109K |
|
3009
NextDecade
NEXT
$1.78B
| $1.14M | ﹤0.01% |
210,962
+195
| +0.1% | +$984 |
|
3010
Gyre Therapeutics
GYRE
$744M
| $1.14M | ﹤0.01% |
19,223
+720
| +4% | +$53.1K |
|
|
TBCH
3011
Turtle Beach Corp
TBCH
$277M
| $1.14M | ﹤0.01% |
79,725
+5,024
| +7% | +$86.4K |
|
|
AXNX
3012
DELISTED
Axonics, Inc. Common Stock
AXNX
| $1.14M | ﹤0.01% |
+75,145
| New | +$1.12M |
|
3013
Information Services Group
III
$251M
| $1.13M | ﹤0.01% |
267,073
+14,636
| +6% | +$61.6K |
|
3014
Oil-Dri
ODC
$1.34B
| $1.13M | ﹤0.01% |
85,356
+4,328
| +5% | +$66.2K |
|
|
TTOO
3015
DELISTED
T2 Biosystems, Inc
TTOO
| $1.13M | ﹤0.01% |
75
+3
| +4% | +$70.5K |
|
|
CVIA
3016
DELISTED
Covia Holdings Corporation Common Stock
CVIA
| $1.13M | ﹤0.01% |
330,598
+16,448
| +5% | +$99.1K |
|
|
NETI
3017
DELISTED
Eneti Inc.
NETI
| $1.13M | ﹤0.01% |
21,946
+3,531
| +19% | +$201K |
|
|
IOTS
3018
DELISTED
Adesto Technologies Corp
IOTS
| $1.13M | ﹤0.01% |
256,051
+9,389
| +4% | +$44.8K |
|
|
EOD
3019
Allspring Global Dividend Opportunity Fund
EOD
$286M
| $1.13M | ﹤0.01% |
242,531
+206,918
| +581% | +$1.05M |
|
3020
MakeMyTrip
MMYT
$5.64B
| $1.12M | ﹤0.01% |
46,199
-820
| -2% | -$19.7K |
|
|
CHAP
3021
DELISTED
Chaparral Energy, Inc.
CHAP
| $1.12M | ﹤0.01% |
228,582
+41,626
| +22% | +$530K |
|
3022
Harvard Bioscience
HBIO
$29.2M
| $1.12M | ﹤0.01% |
35,283
+1,838
| +5% | +$72.5K |
|
|
SCTL
3023
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $1.12M | ﹤0.01% |
176,118
+19,289
| +12% | +$121K |
|
|
INSY
3024
DELISTED
Insys Therapeutics, Inc.
INSY
| $1.12M | ﹤0.01% |
320,314
+8,064
| +3% | +$56K |
|
3025
iRadimed
IRMD
$1.18B
| $1.12M | ﹤0.01% |
45,822
+1,690
| +4% | +$45.4K |
|
Similar funds
Geode Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Geode Capital Management held 4,266 positions worth $323B, down 8.8% from $355B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Geode Capital Management deployed $21.9B of net new capital in Q4 2018, opening 149 new positions and adding to 3,108 existing holdings. Its largest new stake was Linde: 6,406,340 shares worth $998M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Dell, an estimated $92.5M trimmed.
- Geode Capital Management's largest Q4 2018 buy was Linde: 6,406,340 shares worth $998M.
- Geode Capital Management added most to Microsoft in Q4 2018, an estimated $761M increase.
- Geode Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $92.5M.
- Geode Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $741M.
- Geode Capital Management's ten largest holdings make up 17% of its $323B portfolio in Q4 2018.
- Geode Capital Management opened 149 new positions and closed 120 in Q4 2018.
- Geode Capital Management's portfolio value fell 8.8% quarter-over-quarter to $323B.
Based on Geode Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.